AlbemarleMIL:1ALB -2.76%52 Future 3-5Y Total Revenue Growth Rate is 10.24 as of Jun. 24, 2026. GuruFocus rates MIL:1ALB with a GF Score™ of 52/100 and a GF Value™ of €73.68 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 398 Chemicals companies, Albemarle ranks better than 57.54% on this metric.
Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.
As of today, Albemarle's Future 3-5Y Total Revenue Growth Rate is 10.24.
Albemarle (MIL:1ALB) Future 3-5Y Total Revenue Growth Rate Explanation
Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Albemarle Future 3-5Y Total Revenue Growth Rate Related Terms
MIL:1ALB vs LYB, DD, IFF: Future 3-5Y Total Revenue Growth Rate Comparison
For the Specialty Chemicals subindustry, Albemarle's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Albemarle Future 3-5Y Total Revenue Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Albemarle's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Albemarle's Future 3-5Y Total Revenue Growth Rate falls into.
What does a Future 3-5Y Total Revenue Growth Rate of 10.24 mean?
Albemarle (MIL:1ALB) has a Future 3-5Y Total Revenue Growth Rate of 10.24 as of Jun. 24, 2026. Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period. View historical data for Albemarle and its competitors. According to the industry distribution chart, Albemarle ranks #169 out of 398 companies in the Chemicals industry, placing it in the top 42.5%.
Is Albemarle's Future 3-5Y Total Revenue Growth Rate too high?
Albemarle's current Future 3-5Y Total Revenue Growth Rate is 10.24. The Chemicals industry median Future 3-5Y Total Revenue Growth Rate is 8.48. Albemarle's value of 10.24 is 20.8% above this industry median. Based on the distribution chart, Albemarle ranks #169 out of 398 companies in the Chemicals industry, which is above the industry midpoint. Overall, Albemarle has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Albemarle's Future 3-5Y Total Revenue Growth Rate compare to LYB and DD?
According to the Chemicals industry distribution chart, Albemarle ranks #169 out of 398 companies for Future 3-5Y Total Revenue Growth Rate. This puts Albemarle in the upper half of its industry. The industry median Future 3-5Y Total Revenue Growth Rate is 8.48. Albemarle's value of 10.24 is 20.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y Total Revenue Growth Rate for a Chemicals company?
The median Future 3-5Y Total Revenue Growth Rate among Chemicals companies is 8.48, based on 398 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y Total Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y Total Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Albemarle's current Future 3-5Y Total Revenue Growth Rate of 10.24 is 20.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y Total Revenue Growth Rate mean?
A high Future 3-5Y Total Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period. View historical data for Albemarle and its competitors. For the Chemicals industry, the median Future 3-5Y Total Revenue Growth Rate is 8.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albemarle's current Future 3-5Y Total Revenue Growth Rate is 10.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albemarle stock overvalued right now?
Based on GuruFocus' analysis, Albemarle (MIL:1ALB) is currently considered Significantly Overvalued. The stock's GF Value™ is €73.68, compared to a current price of €132.35 — trading 79.6% above its estimated fair value. The current Future 3-5Y Total Revenue Growth Rate is 10.24 and 20.8% above the Chemicals industry median of 8.48. Albemarle's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y Total Revenue Growth Rate calculated?
Future 3-5Y Total Revenue Growth Rate is calculated from a company's financial statements. For Albemarle (MIL:1ALB), the current Future 3-5Y Total Revenue Growth Rate is 10.24 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Albemarle (MIL:1ALB) Overvalued in 2026?
Based on GuruFocus' analysis, Albemarle stock appears to be overvalued.
The current stock price of €132.35 is trading 79.6% above its estimated GF Value™ of €73.68.
GuruFocus considers Albemarle to be Significantly Overvalued.
Key valuation signals for MIL:1ALB:
Future 3-5Y Total Revenue Growth Rate: 10.24
GF Value™: €73.68 vs. price of €132.35 (79.6% above fair value)
Industry Position: 20.8% above the Chemicals median (#169 of 398)
No single metric tells the full story. See the MIL:1ALB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
52GF Score
Get the complete analysis for MIL:1ALB
Future 3-5Y Total Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1ALB has been successfully added to your 